Improving Serine Protease Inhibitors for Cancer Treatment
Author Information
Author(s): Swedberg Joakim E., de Veer Simon J., Sit Kei C., Reboul Cyril F., Buckle Ashley M., Harris Jonathan M.
Primary Institution: Institute of Health and Biomedical Innovation, Queensland University of Technology
Hypothesis
Can optimizing the internal hydrogen bond network of serine protease inhibitors enhance their potency and selectivity?
Conclusion
The study found that maintaining structural rigidity in the binding loop is crucial for enhancing the potency of serine protease inhibitors.
Supporting Evidence
- SFTI-FCQR Asn14 showed a 125-fold increase in inhibition capacity for KLK4.
- The inhibitor was stable in cell culture and bioavailable in mice.
- Internal hydrogen bond frequency correlated with enhanced inhibition potency.
Takeaway
Scientists made a better medicine to fight prostate cancer by changing how a protein sticks to its target, making it work much better.
Methodology
The study used in silico screening and molecular dynamics simulations to analyze the effects of amino acid substitutions on the internal hydrogen bonding network of serine protease inhibitors.
Limitations
The study primarily focused on in vitro results, which may not fully translate to in vivo efficacy.
Statistical Information
P-Value
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website